PATENT CLAIM ANALYSIS

Application Number: 15950962
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "174100"]

Abstract:
Compositions specific for TNF-receptor superfamily member 25 (TNFRSF25, DR3) modulate the immune re-sponse by regulating T regulatory cells.

Claim (Index 9):
The method of  claim 8 , wherein the agent is an agonist of TNFRSF25.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 91.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13388722', '14185295', '13457583', '14764024', '15618993']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7453577659924693
- 35 USC 102 Novelty (BERT): 0.5805558339328045
- Combined Prediction Score: 0.7288775727865028
- Mean Citation Score: 404.709968
- Max Citation Score: 625.76917
- Similarity Product: 343.76571132094625

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test